CIK 0001745648 · <br>Emerging growth company
Apnimed, Inc.
Sign in to watch- Ticker
- APMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821910611
- Phone
- 617-500-8880
- Business address
- 39 JOHN F. KENNEDY STREET, 4TH FLR., CAMBRIDGE, MA, 02138
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company | −88,954 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award | +88,954 | 88,954 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company | −88,954 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award | +88,954 | 88,954 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company | −88,954 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award | +88,954 | 88,954 | ||
| 2026-08-03 | Miller Lawrence G. Director | Conversion · Series A Preferred Stock | −10,845 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −688,042 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +688,042 | 688,042 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −98,843 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +98,843 | 98,843 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −302,541 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +302,541 | 302,541 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −333,580 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +333,580 | 333,580 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −333,580 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +333,580 | 333,580 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −333,580 | 0 | ||
| 2026-08-03 | Miller Lawrence G. Director | Grant or award · Stock Option (Right to Buy) | +333,580 | 333,580 | ||
| 2026-08-03 | Miller Lawrence G. Director | Returned to the company · Stock Option (Right to Buy) | −59,303 | 0 |
Page 3 of 6 · 104 trades